Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data

Risk assessment in cutaneous melanoma (CM) patients is one of the major challenges in the effective treatment of CM patients. Traditionally, clinico-pathological features such as Breslow thickness, American Joint Committee on Cancer (AJCC) tumor staging, etc. are utilized for this purpose. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Chakit, Kaur, Dilraj, Lathwal, Anjali, Raghava, Gajendra P.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472860/
https://www.ncbi.nlm.nih.gov/pubmed/32913910
http://dx.doi.org/10.1016/j.heliyon.2020.e04811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472860/
https://www.ncbi.nlm.nih.gov/pubmed/32913910
http://dx.doi.org/10.1016/j.heliyon.2020.e04811

Ejemplares similares